FDA.reportPublic FDA data

Conazol Spray Powder

Manufacturer
MarcasUSA LLC | Laboratorios Liomont, S.A. de C.V.
Effective date
2020-01-27
Label type
HUMAN OTC DRUG LABEL
Version
2
Source
full-release
Hydrated at
2026-05-31 23:03:28

Label at a glance#

ProductConazol
Active ingredientMICONAZOLE NITRATE
Label structure22 sections

Dosage and administration

wash affected area and dry thoroughly shake can well and spray a thin layer over affected area twice daily (morning and night) or as directed by a doctor supervise children in the use of this product for athlete's foot, pay special attention to the spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily use daily for 4 weeks for athlete's foot and ringworm; use ...

Storage and handling

store between 20° and 30°C (68° and 86°F)

Label contents#

Full prescribing information#

Active Ingredients Purpose

OTC - ACTIVE INGREDIENT SECTION

Active ingredients
Miconazole nitrate 2% 		Purpose
Antifungal

INDICATIONS & USAGE SECTION

Uses

OTC - PURPOSE SECTION

  • effective in the treatment of most athlete's foot, jock
    itch and ringworm
  • relieves itching, cracking, burning and discomfort
    associated with these conditions

Warnings

WARNINGS SECTION

For external use only

Flammable: Do not use while smoking or near heat or flame. Do not puncture or incinerate. Contents under pressure. Do not store at temperature above 120°F (49°C).

When using this product

OTC - WHEN USING SECTION

  • avoid contact with the eyes or mouth
  • use only as directed
  • intentional misuse by deliberately concentrating and inhaling contents can be harmful or fatal

Stop use and ask a doctor if

OTC - ASK DOCTOR SECTION

  • irritation occurs
  • no improvement within 4 weeks for athlete's foot and ringworm; 2 weeks for jock itch

Keep out of reach of children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

If swallowed, get medical help or contact a Poison Control Center right away. Do not use on children under 2 years of age unless directed by a doctor.

Directions

DOSAGE & ADMINISTRATION SECTION

  • wash affected area and dry thoroughly
  • shake can well and spray a thin layer over affected area twice daily (morning and night) or as directed by a doctor
  • supervise children in the use of this product
  • for athlete's foot, pay special attention to the spaces between the toes; wear well-fitting, ventilated shoes, and change shoes and socks at least once daily
  • use daily for 4 weeks for athlete's foot and ringworm; use daily for 2 weeks for jock itch
  • if condition persists, consult a doctor
  • this product is not effective on the scalp or nails
  • in case of clogging, clear nozzle under running water

Other Information

STORAGE AND HANDLING SECTION

store between 20° and 30°C (68° and 86°F)

Inactive Ingredients

INACTIVE INGREDIENT SECTION

isobutane (propellant), SD alcohol 40-B (14% w/w), stearalkonium hectorite, talc

Questions?

SPL UNCLASSIFIED SECTION

Call Toll-Free 1-800-428-9489

Distributed By: MarcasUSA, LLC, El Segundo, CA 90245

SPL UNCLASSIFIED SECTION

Datos de Medicamento

OTC - ACTIVE INGREDIENT SECTION

Ingrediente Activo
Nitrato de miconazol 2%		Propósito
Antimicótico

Usos

OTC - PURPOSE SECTION

  • eficaz para el tratamiento de la mayoría del pie de atleta, tiña inguinal y tiña
  • alivia la comezón, grietas, ardor y molestias asociadas con estas condiciones

Precauciones

WARNINGS SECTION

Sólo para uso externo

lnflamable: No usar cerca de flamas, chispas o cuando fume. No perfore ni incinere. Contenido bajo presión. No almacene en temperatura sobre 120°F (49°C).

Al utilizar este producto

OTC - WHEN USING SECTION

  • evite el contacto con los ojos o la boca
  • utilizar solo como se indica
  • el uso malintencionado, concentrar e inhalar el contenido puede ser dañino o fatal.

Deje de usar y consulte al médico, si

OTC - ASK DOCTOR SECTION

  • presenta irritación
  • no hay mejoria del pie de atleta o tiña en un plazo de 4 semanas o tiña inguinal dentro de 2 semanas

Mantener fuera del alcance de los niños.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

En caso de ingestión, obtenga ayuda médica o contacte a un Poison Control Center inmediatamente. No lo use en niños menores de 2 años de edad a menos que lo indique un médico.

Modo de empleo

DOSAGE & ADMINISTRATION SECTION

  • limpie y seque bien el área afectada
  • agite bien el envase antes de usar
  • aplique una capa fina del producto sobre el área afectada dos veces al día (mañana y noche) o según las indicaciones de un médico
  • supervise a los niños en el uso de este producto
  • para el pie de atleta, poner especial atención a los espacios entre los dedos de los pies, usar zapatos ventilados y cómodos, cambiar los calcetines y zapatos al menos una vez al día
  • para el pie de atleta y tiña usar diariamente por 4 semanas
  • para tiña inguinal, usar diariamente por 2 semanas
  • si no hay mejora, consulte a su médico
  • no es eficaz en el cuero cabelludo o las uñas
  • en caso de obstrucción, limpiar boquilla bajo agua corriente

Otra información

STORAGE AND HANDLING SECTION

almacene de 20° a 30°C (68° a 86° F)

Ingredientes Anactivos

INACTIVE INGREDIENT SECTION

isobutano (propelente), SD alcohol 40-B (14% w/w), estearalconio hectorita, talco

¿Preguntas?

SPL UNCLASSIFIED SECTION

Llame al 1-800-428-9489

Distributed By: MarcasUSA, LLC, El Segundo, CA 90245

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

Maximum StrengthNDC 75940-127-46

Conazol
Antifungal

MICONAZOLE NITRATE 2%

SPRAY POWDER
SPRAY EN POLVO

Cures Most
Athlete's Foot

Cura la Mayoría del
Pie de Atleta

Relieves Itching, Burning & Cracking

Alivia la Comézon, Ardor & Grietas

LIOMONT

NET WT
4.6 OZ
Peso Neto 130 g

Container LabelContainer Label

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
998428miconazole nitrate 2 % Powder SprayPSN2
998428miconazole nitrate 0.02 MG/MG Powder SpraySCD2
998428miconazole nitrate 2 % Powder SpraySY2

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
MICONAZOLE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
3a55f4fb-5aec-4c88-0ff7-4d608ad4866aProduct name120140508
5b9a7965-36d2-8412-dcaf-f76a65411611Product name120140508

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
75940-127-462020-09-27C16284748780-1ab0e2407-2807-f274-e053-dbdaa90a6471Conazol Spray Powder
75940-127-462020-09-25C16284748780-1ab0e2407-2807-f274-e053-dbdaa90a6471Conazol Spray Powder
75940-127-462020-07-22C16284748780-1ab0e2407-2807-f274-e053-dbdaa90a6471Conazol Spray Powder

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
75940-127-46Conazol130 g in 1 CANSPRAY1302

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
75940-127CONAZOL (MICONAZOLE NITRATE) SPRAY [MARCASUSA LLC]2Legacy NDC, 1 package rows20200128_54c2ead1-8b2d-4024-ab16-ae6bd2644994.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
MICONAZOLE NITRATEACTIVE INGREDIENTVW4H1CYW1K1
MICONAZOLEACTIVE MOIETY7NNO0D7S5M1
ALCOHOLINACTIVE INGREDIENT3K9958V90M1
ISOBUTANEINACTIVE INGREDIENTBXR49TP6111
STEARALKONIUM HECTORITEINACTIVE INGREDIENTOLX698AH5P1
TALCINACTIVE INGREDIENT7SEV7J4R1U1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
75940-12775940-127-46

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Name, UNII, Kind table
NameUNIIKind
MICONAZOLE NITRATEVW4H1CYW1KACTIB
ISOBUTANEBXR49TP611IACT
ALCOHOL3K9958V90MIACT
STEARALKONIUM HECTORITEOLX698AH5PIACT
TALC7SEV7J4R1UIACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 98 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
ALCOHOLALCOHOL3K9958V90MINJECTION, SOLUTION / INTRAVENOUS6405 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / TRANSDERMAL49.37 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / INTRAVESICAL7892 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL, FOAM / TOPICAL4504 mgExact identifier — unii candidate
59 equally ranked IID candidates
TALCTALC7SEV7J4R1USUSPENSION, EXTENDED RELEASE / ORAL46 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UPELLET / ORAL69 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UPOWDER, FOR SUSPENSION / ORAL735 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1USUSPENSION / ORAL234 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UGRANULE / ORAL322 mgExact identifier — unii candidate
35 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION, CONCENTRATE / INTRAVENOUS4000 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSPRAY / SUBLINGUAL397 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION / INTRAVASCULAR100 %v/vExact identifier — unii candidate
59 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, EXTENDED RELEASE / ORAL300 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, SUGAR COATED / ORALNAExact identifier — unii candidate
35 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION, SOLUTION / INTRAMUSCULAR1000 mgExact identifier — unii candidate
59 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, DELAYED RELEASE PARTICLES / ORAL56 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UCAPSULE, COATED PELLETS / ORAL14 mgExact identifier — unii candidate
35 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSPRAY, METERED / SUBLINGUAL29 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MGEL / DENTAL1.8 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSHAMPOO / TOPICAL714 mgExact identifier — unii candidate
59 equally ranked IID candidates
TALCTALC7SEV7J4R1UCAPSULE, COATED / ORAL87 mgExact identifier — unii candidate
35 equally ranked IID candidates
ISOBUTANEISOBUTANEBXR49TP611AEROSOL, SPRAY / TOPICAL4484 mgExact identifier — unii candidate
4 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, DELAYED RELEASE / ORAL349 mgExact identifier — unii candidate
35 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL / TOPICAL561 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MPOWDER, FOR SOLUTION / TOPICAL40 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MGEL / TOPICAL9971 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MELIXIR / ORAL13675 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION, CONCENTRATE / ORAL150.68 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
TALCTALC7SEV7J4R1UCAPSULE, DELAYED RELEASE / ORAL420 mgExact identifier — unii candidate
35 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MLIQUID / RESPIRATORY (INHALATION)5 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, COATED / ORAL320.75 mgExact identifier — unii candidate
35 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / NASAL10 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MLOTION / TOPICAL25 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION / INTRAVENOUS92 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, CHEWABLE, EXTENDED RELEASE / ORAL18 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UCAPSULE, EXTENDED RELEASE / ORAL5119 mgExact identifier — unii candidate
35 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MGEL / RECTAL898 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MCAPSULE, EXTENDED RELEASE / ORAL8 mgExact identifier — unii candidate
59 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, CHEWABLE / ORAL202 mgExact identifier — unii candidate
35 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSPRAY / TOPICAL3633 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MAEROSOL, METERED / NASAL70 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / ORAL6624 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MGEL, METERED / TOPICAL541 mgExact identifier — unii candidate
59 equally ranked IID candidates
TALCTALC7SEV7J4R1UGUM, CHEWING / BUCCALNAExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UGRANULE, FOR SUSPENSION / ORAL296 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UGRANULE, DELAYED RELEASE / ORAL525 mgExact identifier — unii candidate
35 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MGEL / TRANSDERMAL7360 mgExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MSOLUTION / OPHTHALMIC0.5 %w/vExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MDROPS / ORAL210 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MPASTE / DENTAL1.8 %w/wExact identifier — unii candidate
59 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET, ORALLY DISINTEGRATING, DELAYED RELEASE / ORAL357 mgExact identifier — unii candidate
35 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION, SOLUTION / SUBCUTANEOUS6.1 %v/vExact identifier — unii candidate
59 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MJELLY / VAGINALNAExact identifier — unii candidate
59 equally ranked IID candidates
TALCTALC7SEV7J4R1UCAPSULE / ORAL729 mgExact identifier — unii candidate
35 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MCONCENTRATE / BUCCAL679 mg/1mlExact identifier — unii candidate
59 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET / BUCCAL15 mgExact identifier — unii candidate
35 equally ranked IID candidates
TALCTALC7SEV7J4R1UTABLET / ORAL1000 mgExact identifier — unii candidate
35 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MINJECTION / SUBCUTANEOUS149 mgExact identifier — unii candidate
59 equally ranked IID candidates
TALCTALC7SEV7J4R1UCAPSULE, COATED, EXTENDED RELEASE / ORAL20 mgExact identifier — unii candidate
35 equally ranked IID candidates
ALCOHOLALCOHOL3K9958V90MCONCENTRATE / ORAL198 mgExact identifier — unii candidate
59 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
02ec55d1-3925-4f71-984c-3ff1697ffe3f54c2ead1-8b2d-4024-ab16-ae6bd26449942020-01-27WarningsExact identifier
spl id: 02ec55d1-3925-4f71-984c-3ff1697ffe3f
spl set id: 54c2ead1-8b2d-4024-ab16-ae6bd2644994

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.